Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2023/543 of 9 March 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 (Text with EEA relevance)

Type Implementing Regulation

Publication 2023-03-10

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 2

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


10.3.2023	EN	Official Journal of the European Union	L 73/1

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC ¹, and in particular Article 19 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) No 686/2012 ² allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.

(2) That allocation should be made in a way that ensures a balance between Member States as regards the distribution of the responsibilities and the work.

(3) Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.

(4) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 9 March 2023.

For the Commission

The President

Ursula VON DER LEYEN

OJ L 309, 24.11.2009, p. 1.

Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5).

ANNEX

In the Annex to Implementing Regulation (EU) No 686/2012, the following Part E is added:

‘PART E

Allocation of the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035

Active substance	Rapporteur Member State	Co-rapporteur Member State
1-methylcyclopropene	DE	EL
2,4-D	DE	EL
2,4-DB	EL	IE
ABE-IT 56	FR	PT
Acetamiprid	DE	ES
Acibenzolar-S-methyl	ES	BE
Ampelomyces quisqualis strain AQ10	SE	NL
Bacillus amyloliquefaciens strain FZB24	DE	AT
Bacillus subtilis strain IAB/BS03	ES	AT
Beauveria bassiana strain 203	DK	NL
Beauveria bassiana strain IMI389521	SE	NL
Beauveria bassiana strain PPRI 5339	SE	NL
Benzoic acid	HU	CZ
Carfentrazone-ethyl	FR	DE
Carvone	IT	NL
Cerevisane	ES	DE
Clonostachys rosea strain J1446	HU	AT
Coniothyrium minitans strain CON/M/91-08	AT	EE
COS-OGA	FR	HR
Cyhalofop-butyl	CZ	BE
Cypermethrin	CZ	DE
Dimethenamid-P	BE	DE
Ethofumesate	AT	FI
Fenhexamid	BE	CZ
Ferric phosphate	PL	DK
Ferric pyrophosphate	CZ	FR
Flazasulfuron	ES	PL
Florasulam	CZ	FR
Florpyrauxifen-benzyl	FR	IT
Flutianil	DE	EL
Foramsulfuron	FR	SK
Forchlorfenuron	ES	BE
Iodosulfuron	BE	FR
Iprovalicarb	SE	LV
Isaria fumosorosea strain Apopka 97	NL	AT
Isoxaflutole	SE	BE
Laminarin	EL	FR
Lavandulyl senecioate	SE	NL
Maleic hydrazide	SI	IT
Mefentrifluconazole	ES	FR
Mesosulfuron	PL	SE
Mesotrione	NL	SK
Metalaxyl-M	DE	EL
Mild Pepino Mosaic Virus isolate VC 1	FR	DE
Mild Pepino Mosaic Virus isolate VX 1	FR	DE
Pasteuria nishizawae Pn1	NL	DK
Pepino mosaic virus strain CH2 isolate 1906	FI	BE
Pethoxamid	AT	FR
Phlebiopsis gigantea strain FOC PG 410.3	EE	FI
Phlebiopsis gigantea strain VRA 1835	EE	FI
Phlebiopsis gigantea strain VRA 1984	EE	FI
Picolinafen	LT	IT
Propoxycarbazone	SE	BE
Pyraflufen-ethyl	DE	FR
Pyridate	AT	DE
Pyriproxyfen	ES	BE
Saccharomyces cerevisiae strain LAS02	EL	AT
Silthiofam	NL	IE
Sodium hydrogen carbonate	AT	FR
Sulfosulfuron	IE	SE
Thiabendazole	NO	ES
Thifensulfuron-methyl	FR	DK
Tolclofos-methyl	FI	SE
Tribenuron	FR	SE
Trichoderma atroviride strain SC1	SI	NL
Trifloxystrobin	HR	DE
Verticillium albo-atrum strain WCS850	NL	SE
Zoxamide	BE	PL’

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.